Content
12/04/2023
Cambridge, MA USA
Seismic Therapeutic
completed $121 million Series B Round funding. Investors include
Bessemer Venture Partners (lead), Alexandria Venture Investments, Amgen Ventures, Boxer Capital, Codon Capital, Gaingels, Google Ventures, Lightspeed Venture Partners, Polaris Partners, Samsara BioCapital.
About
We are The Machine Learning Immunology Company. Seismic Therapeutic is a biotechnology company integrating machine learning across the entire biologics drug discovery and development process. Using our IMPACT™ platform, we are fully integrating machine learning with the key elements of biologics drug discovery – structural biology, protein engineering and translational immunology – to create optimized therapies for patients. Seismic Therapeutic has an emerging pipeline of novel approaches to address adaptive immune system dysregulation to treat autoimmune diseases. The company is backed by a strong syndicate of life sciences investors and is located in the Boston biotechnology hub.
Startup
Sector:
Biotech
Life Science
Download StockFan App
Ad
Stock market data, news and community, all integrated.
Features include real time stock quotes, interactive charts, technical signals, institutional & insider ownerships, stock screener, ETF rankings, SEC filings, press releases, videos, earnings calendar, social media posts, group chats.
